Despite recent advances in N 6 -methyladenosine (m 6 A) biology, the regulation of crucial RNA processing steps by the RNA methyltransferase-like 3 (METTL3) in glioma stem-like cells (GSCs) remains obscure. An integrated analysis of m 6 A-RIP (RNA immunoprecipitation) and total RNA-Seq of METTL3-silenced GSCs identified that m 6 A modification in GSCs is principally carried out by METTL3. The m 6 A-modified transcripts showed higher abundance compared to non-modified transcripts. Further, we showed that the METTL3 is essential for the expression of GSC-specific actively transcribed genes. Silencing METTL3 resulted in the elevation of several aberrant alternative splicing events. We also found that putative m 6 A reader proteins play a key r...
RNA N6-methyladenosine (m6A) modification plays important roles in multiple aspects of RNA regulatio...
RNA N6-methyladenosine (m6A) modification plays important roles in multiple aspects of RNAregulation...
Acquired chemoresistance is a major limiting factor in the clinical treatment of glioblastoma (GBM)....
Despite recent advances in N 6 -methyladenosine (m 6 A) biology, the regulation of crucial RNA proce...
Despite recent advances in N6-methyladenosine (m6A) biology, the regulation of crucial RNA processin...
Despite advances in biology and therapeutic modalities, existence of highly tumorigenic glioma stem-...
Despite advances in biology and therapeutic modalities, existence of highly tumorigenic glioma stem-...
Abstract As one of the most abundant epigenetic modifications in RNA, N6-methyladenosine (m6A) affec...
N6-methyladenosine (m6A) is a highly prevalent mRNA modification that promotes degradation of transc...
Fundamentally, biological life depends on precise regulation of the expression of genetic informatio...
N6-methyladenosine (m6A) is one of the most widespread and abundant internal messenger RNA modificat...
N6-methyladenosine (m6A) is one of the most widespread and abundant internal messenger RNA modificat...
N6-methyladenosine (m6A) is one of the most widespread and abundant internal messenger RNA modificat...
Glioblastoma is the most common and most lethal primary malignant brain tumor. N6-methyladenosine (m...
N6-methyladenosine (m6A) is one of the most widespread and abundant internal messenger RNA modificat...
RNA N6-methyladenosine (m6A) modification plays important roles in multiple aspects of RNA regulatio...
RNA N6-methyladenosine (m6A) modification plays important roles in multiple aspects of RNAregulation...
Acquired chemoresistance is a major limiting factor in the clinical treatment of glioblastoma (GBM)....
Despite recent advances in N 6 -methyladenosine (m 6 A) biology, the regulation of crucial RNA proce...
Despite recent advances in N6-methyladenosine (m6A) biology, the regulation of crucial RNA processin...
Despite advances in biology and therapeutic modalities, existence of highly tumorigenic glioma stem-...
Despite advances in biology and therapeutic modalities, existence of highly tumorigenic glioma stem-...
Abstract As one of the most abundant epigenetic modifications in RNA, N6-methyladenosine (m6A) affec...
N6-methyladenosine (m6A) is a highly prevalent mRNA modification that promotes degradation of transc...
Fundamentally, biological life depends on precise regulation of the expression of genetic informatio...
N6-methyladenosine (m6A) is one of the most widespread and abundant internal messenger RNA modificat...
N6-methyladenosine (m6A) is one of the most widespread and abundant internal messenger RNA modificat...
N6-methyladenosine (m6A) is one of the most widespread and abundant internal messenger RNA modificat...
Glioblastoma is the most common and most lethal primary malignant brain tumor. N6-methyladenosine (m...
N6-methyladenosine (m6A) is one of the most widespread and abundant internal messenger RNA modificat...
RNA N6-methyladenosine (m6A) modification plays important roles in multiple aspects of RNA regulatio...
RNA N6-methyladenosine (m6A) modification plays important roles in multiple aspects of RNAregulation...
Acquired chemoresistance is a major limiting factor in the clinical treatment of glioblastoma (GBM)....